Sphere Fluidics’ Blogs

The benefits of switching to picodroplet-based technologies for antibody discovery.

Dr Tristan Vaughan shares his perspectives on biological medicines development, the potential for single cell analysis platforms in advancing the field.

This blog discusses how the detection of rare cells from large populations by miniaturized immunoassays in picodroplets increases the speed and efficiency of selective cell screening and reduces screening costs.

Dr Fay Saunders, UK Head of Upstream Mammalian Cell Culture, Process Development at FUJIFILM Diosynth Biotechnologies, shares her experience of using Cyto-Mine® in cell line development and recombinant protein expression.

This article outlines some techniques and tips from our Senior Service Engineer, Darren Matthews, on optimizing PMT settings using Cyto-Mine®.

Jon Dempsey, Pathway Biopharma, shares how companies can improve product quality and yields, as well as shorten overall cell line development timelines.

Cyto-Mine® reduces the cell line development process by 3 months, enabling researchers to make a new vaccine much faster